Dataset

Nalidixic acid, 389-08-2.dept

Nalidixic acid, 389-08-2

InChI	InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)
SMILES	CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2
InChI Key	MHWLWQUZZRMNGJ-UHFFFAOYSA-N
Molecular Formula	C12H12N2O3
Exact Mass	232.230 g/mol

Data and Resources

Field	Value
DOI	10.57992/nmrxiv.p12.s74.d428
License URL	https://creativecommons.org/licenses/by/4.0/legalcode
Source	https://nmrxiv.org/D428
Version
Author	Mohr J, Porwal D, Chatterjee I, Oestreich M.
Maintainer
Language	english
MetadataCreated	2024-04-22T15:50:08.642617
MetadataModified	2024-09-23T09:29:42.887562
MetadataPublished	2022-11-09 09:57:24

Field	Value
Measurement Technique	distortionless enhancement with polarization transfer
Measurement Variables	NMR solvent : CDCl3 acquisition nucleus : ['13C'] NMR spectrum by dimensionality : 1 NMR probe : 5 mm PABBO BB-1H/19F/D Z-GRD Z129133/0001 Temperature : 298.0886 K magnetic field strength : 16.441106362506158 Tesla number of scans : 16 scans nuclear magnetic resonance pulse sequence : deptsp Spectral Width : 253.539406748764 number of data points : 7 points relaxation time measurement : 2.2 seconds

Data-Source Molecule ID	Data-Source
20123603	NMRShiftDB
MCULE-6808033849	Mcule
SCHEMBL21736	SureChEMBL
Nalidixic-acid(NegGram)	Selleck
PA164746384	PharmGKB
389-08-2	ACToR
LSM-5590	LINCS
3B91HWA56M	FDA SRS
PD001597	ProbesDrugs
4421	PubChem
14773844	PubChem: Thomson Pharma
HMDB0014917	Human Metabolome Database
2148	Brenda
CB1194283	ChemicalBook
114048	Brenda
529362	eMolecules
DB00779	DrugBank
C05079	KEGG Ligand
CHEMBL5	ChEMBL
SAM002554914	NIH Clinical Collection
100147	ChEBI
NIX	PDBe
DTXSID3020912	EPA CompTox Dashboard
1875	DrugCentral
ZINC000000057421	ZINC
NEGGRAM	clinicaltrials
HY-B0398	MedChemExpress
NALIDIXIC ACID	clinicaltrials
NALIDIXATE SODIUM	clinicaltrials
NALIDIXIC ACID	rxnorm
21691	BindingDB
NALIDIXATE	rxnorm
NALIDX	CCDC
J2.039G	Nikkaji
The data in this table is sourced from UniChem at EBI.